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Sto assess minimal stent diameter and area (MSD and MSA). Stent expansion was
deﬁned as MSD (or MSA) divided by the values predicted by the manufacturers'
compliance charts. Patients were divided into 4 groups according to the median values
of arc and area of calcium.
Results: Mean stent expansion was 73.3  8.7% for MSD and 65.2  12.0% for
MSA. Stent expansion deﬁned by MSD was signiﬁcantly different among the groups
(p ¼ 0.02) (Figure). Similar trend was observed for stent expansion deﬁned by MSA
(p ¼ 0.16).Conclusions: Stent expansion of the 2nd generation DESs may be predicted by the
amount of target lesion calciﬁcation assessed by OCT.
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Background: To examine the endothelial shear stress (ESS) patterns, the neointimal
distribution and the relation between ESS and neointimal thickness (NT) in models
derived from the integration of frequency domain optical coherence tomographic (FD-
OCT) and coronary angiographic data and compare these estimations with those
computed in the traditional reconstructions obtained by the fusion of intravascular
ultrasound (IVUS) and coronary angiography.
Methods: Six segments implanted with an Absorb Bioresorbable Vascular Scaffold
(Absorb BVS) that were investigated with FD-OCT and IVUS examination at baseline
and 6 or 12 months follow-up were included. The IVUS and OCT data acquired at
follow-up were fused separately with the angiographic data to reconstruct the luminal
surface at baseline and follow-up. Blood ﬂow simulation was performed on the
baseline IVUS-based and OCT-based models and computational ﬂuid dynamics
techniques were implemented to assess the ESS and the association between the ESS
and the measured NT at follow-up.
Results: The IVUS-based models appeared to underestimate the neointima
tissue (0.670.59 mm3 vs. 15.145.63 mm3, P¼0.001) compared to the FD-
OCT-based reconstructions. Flow recirculation zones were detected in the FD-
OCT-based reconstructions and the ESS values were lower compared to the
IVUS-based models (1.290.66 Pa vs. 1.870.66 Pa, P¼0.030). These differ-
ences should be attributed to the poor resolution of IVUS that did not allow
visualization of the protruded struts. A statistically signiﬁcant inverse correlation
was noted between the logarithmic ESS at baseline and the NT at follow-up in all
the FD-OCT-based models which was higher than the correlation reported in 5 of
the 6 IVUS-derived models (mean correlation coefﬁcient: -0.520.19 vs.
-0.100.04, P¼0.028).
Conclusions: It appears that the models derived by the fusion of IVUS and coronary
angiography cannot provide enough detail and are incapable of assessing the micro-
environment and its effect on neointima formation following an Absorb BVS
implantation. FD-OCT reconstruction appears superior to IVUS-based reconstruc-
tions and it should be preferred for studying the effect of ESS on neointimal
proliferation.B170 JACC Vol 62/18/Suppl B j October 27–NoveTCT-564
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Background: The aim of this study is to examine the implications of the local
endothelial shear stress (ESS) on neointimal proliferation following an Absorb Bio-
resorbable Vascular Scaffold (BVS) implantation.
Methods: Twelve patients who had an Absorb BVS implantation in a stenotic,
relatively straight arterial segment and who were investigated with serial optical
coherence tomographic examination at baseline and 1 year follow-up were included in
the current analysis. The optical coherence tomographic data acquired at follow-up
were used to reconstruct the treated segment. Blood ﬂow simulation was performed on
the luminal surface at baseline deﬁned by the Absorb BVS struts and the estimated
ESS was related to the neointima thickness measured at 1year follow-up.
Results: The protruded struts appeared to affect the ESS patterns. Low ESS and recircu-
lation zoneswere noted between the struts areas and highESS zones on the top of the struts.
At baseline, , 61% of the measured ESS were <1 Pa. At follow-up, the mean neointima
thickness was 11345 mmwhile the percentage area obstruction was 13.16.6%. Aweak
but statistically signiﬁcant inverse correlation was noted between baseline ESS and neo-
intima thickness at 1year follow-up in all studied segments (correlation coefﬁcient range:
-0.110 to -0.620). Mixed linear regression analysis between baseline ESS and neointima
thickness at follow-up yielded a slope of -29 mm/Pa and a y-intercept of 142 mm.
Conclusions: The hemodynamic micro-environment appears to regulate neointimal
response following an Absorb BVS implantation. These ﬁndings underline the role of
the ESS patterns on vessel wall healing and should be taken into consideration in the
design of bioresorbable devices.
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Background: Biodegradable stent coatings are hoped to improve the vessel wall
healing. ALEX is a new generation, biodegradable polymer-coated, sirolimus-eluting,
cobalt-chromium coronary stent system.
Methods: A prospective, single arm, multi-centre registry enrolled 60 patients with de
novo native coronary lesions treated with ALEX stent and examined the outcomes by
quantitative coronary analysis (QCA) and optical coherence tomography (OCT) at
multiple timepoints (3 subgroups of 20 patients each at 3, 6 and 12 months) to capture
the time course of vessel healing. Stent strut coverage, stent apposition and neointimal
proliferation were assessed by OCT. Safety endpoint was the composite of death,
myocardial infarction, target lesion re-intervention (TLR) and stent thrombosis (ST) at
30 days and 12 month follow-up.
Results: At baseline, reference vessel diameter was 2.85 (IQR 2.45, 3.17) mm, lesion
length was 12.00 (IQR 9.67,14.58), minimal lumen diameter was 1.020.40 mm and
percent diameter stenosis (%DS) was 6511.5 by QCA. We have treated 31% of
lesions type A/B1 and 69% of lesions type B2/C. Median stent diameter was 3.0 (IQR
2.75, 3.50) mm, stent length was 15 (IQR 12; 20) mm. Procedural device success rate
was 98,7% with post-procedural %DS 6.0 (IQR 2.0; 8.5). QCA analysis revealed
median late lumen loss (mm) 0.035 (IQR -0.047, 0.01) at 3 months, 0.17 (IQR -0.01,
0.32) at 6 months, and 0.14 (IQR 0.07, 0.42) at 12 months. The OCT analysis pre-
sented full strut coverage in 96% at 3 months, in 98% at 6 months, and 100% at 12
months. The rate of uncovered stent struts per section (RUST) >0.3 was 3.15% at 3
months, 1.74% at 6 months, and 0% at 12 months of follow-up, and the malapposition
rate was 0.13%, 0.03% and 0.02%, respectively. There was one death (1,7%), one
TLR (1,7%) and no deﬁnite ST at 12th months of follow-up.
Conclusions: Biodegradable polymer-coated, sirolimus-eluting ALEX stent appears
to feature very favourable proﬁle of arterial wall healing already at 3 months postmber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PMimplantation, balanced with a sustained antiproliferative effect up to 12 months of
follow-up. A larger study is warranted to examine the safety of shortening the dual
antiplatelet therapy regimen on this background.
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Background: Angiographically-identiﬁed geographical miss (GM) of atherosclerotic
plaques during percutaneous coronary intervention (PCI) is common. However, the
relationship between GM and the underlying plaque as identiﬁed by virtual histology
intravascular ultrasound (VH-IVUS) as not been studied. We aimed to determine
whether GM is associated with speciﬁc plaque characteristics, PCI-related myocardial
infarction (MI4a) and future major adverse cardiovascular events (MACE).
Methods: Patients with stable angina (n¼100) or myocardial infarction (MI) (n¼70)
underwent 3-vessel VH-IVUS prior to PCI. GM was deﬁned as 3 uncovered VH-
IVUS frames in stented lesions with plaque area >40% at either stent edge. MACE
comprised death, MI, hospitalization with unstable angina or unplanned
revascularization.
Results: 30372mm VH-IVUS and 1096 lesions were analysed: 858 (78.2%) plaques
were unstented, 165 (15.1%) stented without GM, and 80 (7.3%) stented with GM.
GM was associated with increased plaque volume, necrotic core %, dense calcium %
and VH-deﬁned thin cap ﬁbroatheroma (VHTCFA) and with reduced ﬁbrous tissue %
(table). GM was not associated with increased MI4a (33 (54%) vs. 71 (72%), p¼0.15)
or inﬂammatory cytokine release. MACE (n¼43) occurred in 28 patients over
a median follow-up of 1115 [968-1537] days. MACE were directly linked to 11/858
(0.8%) unstented plaques, 7/165 (4.2%) fully covered stented lesions and 8/80 (10%)
stented lesions with GM (log rank p<0.001). In patients presenting with MI, stented
lesions with GM had increased future MACE compared to fully covered lesions (log
rank p¼0.015).Plaque parameters
Completely
covered plaques Geographical miss p value
(n=165) (n=80)
Plaque Burden
70% (n (%))
110 (67%) 62 (78%) 0.058
Minimum luminal
area 4mm2
(n (%))
126 (76%) 54 (68%) 0.18
Remodeling index 1.03 [0.91-1.14] 1.00 [0.91-1.19 0.9
Segment length
(mm)
17 [8-29] 32 [19-51] <0.001
Plaque volume
(mm3)
122 [53-216] 271 [131-443] <0.001
Fibrous tissue (%) 59 [51-66] 55 [48-61] 0.001
Necrotic core (%) 20 [15-26] 25 [18-29] 0.001
Dense calcium (%) 7 [3-12] 10 [6-16] <0.001
VH-IVUS
pathological
intimal thickening
(n (%))
17 (10%) 1 (1%) 0.011
VH-IVUS
ﬁbrocalciﬁc plaque
(n (%))
8 (5%) 5 (6%) 0.65
VH-IVUS thick-
capped
ﬁbroatheroma
(n (%))
17 (10%) 7 (9%) 0.4
VH-IVUS thin-
capped
ﬁbroatheroma
(VHTCFA) (n (%))
111 (67%) 66 (83%) 0.013
Non-calciﬁed
VHTCFA (n (%))
35 (21%) 10 (13%) 0.095
Calciﬁed VHTCFA
(n (%))
80 (48%) 55 (69%) 0.003
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sition and type and with future MACE in MI patients undergoing PCI. Whether the
association of GM with future MACE is independent of adverse plaque anatomy is not
clear and requires a much larger study to determine.
TCT-567
Comparison of vascular response after Everolimus-Eluting Stents and Bare
Metal Stents implantation in ST-segment Elevation Myocardial Infarction
Assessed by Optical Coherence Tomography
Yasushi Ino1, Takashi Kubo1, Tomoyuki Yamaguchi2, Hironori Kitabata1,
Makoto Orii2, Yuichi Ozaki1, Kunihiro Shimamura1, Keisuke Satogami1,
Yasutsugu Shiono3, Yamano Takashi1, Takashi Tanimoto1, Kumiko Hirata1,
Atsushi Tanaka1, Toshio Imanishi1, Takashi Akasaka1
1Wakayama Medical University, Wakayama, Japan, 2Wakayama Medical University,
Wakayama , Japan, 3Wakayama Medical University, wakayama, Japan
Background: Implantation of drug-eluting stents (DES) in patients with ST-segment
elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary
intervention (PCI) reduces in-stent restenosis compared with bare metal stents (BMS),
however, the long-term risk of DES use in STEMI has been pointed. Previous patho-
logical and optical coherence tomography (OCT) study reported that ﬁrst generation
DES use in STEMI resulted in higher rates of uncovered and malapposed stent struts at
follow-up. The long-term safety of second generation everolimus-eluting stents (EES)
use in STEMI remains unknown. We used OCT to examine vascular response including
strut coverage and malapposition in patients with STEMI treated with EES and BMS.
Methods: We enrolled 85 patients with STEMI who underwent primary stenting and
10-month follow-up OCT (EES: 47 patients and BMS 38 patients).
Results: A total of 18244 stent struts were analyzed. There were no signiﬁcant
differences in the percentage of uncovered and malapposed stent struts per lesion
between 2 stents (2.283.08% versus 1.472.46%, P¼0.182 and 0.571.22% versus
0.410.84%,P¼0.499, respectively). Averaged neointimal thickness was smaller in
EES lesions (103  38 mm vs. 385  151 mm, P<0.001). Intra-stent thrombus was
observed in 12.8% of EES lesions and 10.5% of BMS lesions (p ¼ 0.750).
Conclusions: In STEMI patients undergoing primary PCI, there are no signiﬁcant
differences in the percentage of uncovered and malapposed stent struts, and the
incidence of intra-stent thrombus at 10-month follow-up between EES and BMS. On
the other hands, EES as compared with BMS signiﬁcantly reduces neointimal
hyperplasia. EES has a potential to achieve low late loss without sacriﬁcing safety.
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Background: Slow ﬂow or no re-ﬂow phenomenon during coronary intervention is
mainly caused by distal embolization of thrombus and plaque debris, and is associated
with unfavorable long-term clinical outcomes. This phenomenon often occurs in the
patients with acute coronary syndrome (ACS) but also in some patients with stable
angina. However, the high-risk patients of distal embolization are not well understood.
Methods: Consecutive patients with acute myocardial infarction (AMI) (n¼192),
those with unstable angina (UA) (n¼89), and those with stable coronary heart disease
(CHD) (n¼211) who received coronary intervention with ﬁlter-type distal protection
device (Filtrap) were prospectively enrolled. We compared between the groups the
frequency of ﬁlter slow ﬂow/ no-reﬂow phenomenon and of distal embolization
captured by the ﬁlter device. We examined by angioscopy if ruptured plaque was
present at the target lesion and analyzed its association with ﬁlter slow ﬂow/ no
re-ﬂow phenomenon or distal embolization.
Results: Filter slow ﬂow/ no re-ﬂow phenomenon occurred most frequently in AMI
patients, although there was no difference between UA and CHD patients (43% vs.
20% vs. 18%, P<0.001). Filter slow ﬂow/ no re-ﬂow phenomenon occurred more
frequently in the patients with vs. without ruptured plaque in each patient group (AMI
patients: 79% vs. 8%, P<0.001; UA patients: 57% vs. 7%, P¼0.001; CHD patients:
72% vs. 6%, P<0.001). Among the patients without ruptured plaque, the incidence
was not different between the patient groups.
Conclusions: Although AMI patients are at high risk of ﬁlter slow ﬂow/ no re-ﬂow
phenomenon and of distal embolization than UA or CHD patients, the risk was
associated with the presence of ruptured plaque. Patients with ruptured plaque had the
higher risk than those without it regardless of the diagnosis.
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Background: Signiﬁcant plaque shift during stenting can result in side branch
compromise in certain cases. This study aimed to evaluate potential effects ofacts/POSTER/Intravascular Imaging and PCI B171
